Zinzino Q2 Performance Overview

Swedish health‑technology company Zinzino reported that second‑quarter revenue grew 18% year‑over‑year, indicating a notable sales uplift compared with the prior period. The quarter’s EBITDA margin widened to 16.3%, up from 10.0% in the same quarter last year, delivering EBITDA of SEK 153.1 million. Gross profit reached SEK 351.3 million, translating into a gross margin of 37.5% for the quarter.

Operational Highlights

During the quarter Zinzino entered the Colombian market, establishing its first official presence in South America. In addition, the firm launched an artificial‑intelligence‑driven customer‑support tool aimed at improving internal efficiency.

Outlook

The company did not provide any revenue or earnings guidance for the remainder of the fiscal year or the upcoming quarters.